2000
DOI: 10.1016/s0735-1097(00)01013-5
|View full text |Cite
|
Sign up to set email alerts
|

An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes

Abstract: We concluded that the endogenous NO synthase inhibitor ADMA is synthesized in human endothelial cells. Asymmetric dimethylarginine increases endothelial oxidative stress and potentiates monocyte binding. Asymmetric dimethylarginine may be an endogenous proatherogenic molecule.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
147
0
5

Year Published

2002
2002
2018
2018

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 212 publications
(162 citation statements)
references
References 52 publications
7
147
0
5
Order By: Relevance
“…The latter effect can be abolished by antioxidant strategies, which supports the concept that oxidative stress could be linked to the development of impaired vascular function in these patients. Incubation of endothelial cells with ADMA also increased formation of superoxide anions [35]. Consistently, short-term oral supplementation with ascorbic acid was able to improve endothelium-dependent vasodilatation in women with GDM [36].…”
Section: Discussionsupporting
confidence: 52%
“…The latter effect can be abolished by antioxidant strategies, which supports the concept that oxidative stress could be linked to the development of impaired vascular function in these patients. Incubation of endothelial cells with ADMA also increased formation of superoxide anions [35]. Consistently, short-term oral supplementation with ascorbic acid was able to improve endothelium-dependent vasodilatation in women with GDM [36].…”
Section: Discussionsupporting
confidence: 52%
“…29 Furthermore, in the presence of ADMA, endothelial cells generate superoxide anion. 35 Accordingly, it seems reasonable to propose that CMV has multiple effects to impair endothelial NO bioactivity, for example, to induce expression of iNOS, to increase superoxide anion generation, to reduce DDAH activity, and thereby to increase ADMA elaboration.…”
Section: Attenuates Bioactive No In Vascular Cellsmentioning
confidence: 99%
“…The bioavailability of L-arginine is determined by the relative concentrations of ADMA and L-arginine. L-Arginine deficiency leads to uncoupling of NOS and oxidant formation (Boger et al, 2000;. It is established that elevated ADMA contributes to endothelial dysfunction (Raptis et al, 2014), pulmonary inflammation (Klein et al, 2010), and fibrosis (Wells et al, 2009).…”
Section: Introductionmentioning
confidence: 99%